Hepatitis C viral dynamics in serum and the target cell during high-dose daily interferon-α with ribavirin combination therapy and twice-a-day interferon-β therapy
Yasuhiro Asahina(Tokyo Medical and Dental University), Takahiro Sakai(Japanese Red Cross Society, Japan), Osamu Noguchi(Musashino Red Cross Hospital), Namiki Izumi(Musashino Red Cross Hospital), Jun Itakura(Musashino Red Cross Hospital), Kaoru Sakurai(Tokyo Medical and Dental University), Nobuhiko Kanazawa(Musashino Red Cross Hospital), Kaoru Tsuchiya(Musashino Red Cross Hospital), Shozo Miyake(Musashino Red Cross Hospital), Masakatsu Uchihara(Musashino Red Cross Hospital)
Cited by 1
Related Papers
Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC guidelines) 2019 update
|Hepatology Research|2019|539
Aryne-based strategy in the total synthesis of naturally occurring polycyclic compounds
|Chemical Society Reviews|2018|293